BioSpace News Archive

REGENXBIO Inc. announced it will participate in the following upcoming investor conferences.

Labcorp, a leading global life sciences company, announced that members of the executive management team will participate in a fireside chat at the Baird 2022 Global Healthcare Conference on Tuesday, Sept. 13, at 9:05 a.m. ET.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 in New York City.

BELLUS Health Inc. announced that Roberto Bellini, BELLUS Health’s President and Chief Executive Officer, will present a corporate overview of the Company at the H.C. Wainwright Global Investment Conference.

Concert Pharmaceuticals, Inc. announced that it will participate virtually at the H.C. Wainwright 24th Annual Global Investment Conference, and its presentation will be available beginning at 7:00 a.m. ET on September 12, 2022.

GlycoMimetics, Inc., a clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, announced that Edwin Rock, M.D., Ph.D. has joined the executive leadership team as Chief Medical Officer.

Bicycle Therapeutics plc announced that management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13th, 2022 at 10:00 a.m. ET.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), today announced positive topline data from a Phase III clinical trial evaluating LINZESS (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation (FC).

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, announced a poster presentation describing the rationale and design for the Phase 2 trial of LYT-100 in patients with IPF at the European Respiratory Society International Congress.

Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced that the company and its collaborators will present 14 abstracts at the 2022 European Society for Medical Oncology Congress being held virtually and in person in Paris from September 9-13, 2022.